|
KMID : 1040620200260040582
|
|
Clinical and Molecular Hepatology
2020 Volume.26 No. 4 p.582 ~ p.583
|
|
|
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
|
|
Patoulias Dimitrios
Doumas Michael
|
|
|
Abstract
|
|
|
|
|
|
|
KEYWORD
|
|
|
Non-alcoholic fatty liver disease, Sodium-glucose transporter 2 inhibitors, GLP-1RAs, Obesity, Lean
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|